Datafolha: 91% of Brazilians support warning labels about harmful effects on alcoholic beverage bottles.

A Datafolha survey commissioned by ACT Promoção da Saúde reveals that 91% of Brazilians favor the inclusion of more transparent warnings about the health effects of alcohol consumption . The proposed idea includes warnings about chronic diseases, chemical dependency, and accidents associated with alcohol, following the model already adopted on cigarette packs sold in Brazil.

Conducted in September but only released this Thursday, the 30th, the survey interviewed 2,002 people over the age of 18 in all regions of Brazil. The margin of error is two percentage points, plus or minus.

The survey also shows that 69% of respondents support restrictions on beer advertising on television, social media, and at events. Another 73% say that advertising non-alcoholic beer could encourage consumption of alcoholic versions.

The data also points to broad support (79%) for policies that increase taxes on alcoholic beverages. Higher taxation on other items that are harmful to health was also monitored: 67% support taxation on soft drinks; 66% on sweetened beverages; and 64% on ultra-processed foods.

Rejection of electronic cigarettes

Regarding cigarettes and tobacco products, 82% support higher taxation. Another 74% support an annual increase in taxes on the product, which is still considered affordable for young people and low-income individuals.

Anvisa discusses regulation of electronic cigarettes. Photo: Joédson Alves/Agência Brasil

The study also indicates that 78% of those interviewed support the idea that cigarette manufacturers should reimburse the Brazilian public health system (SUS) for the costs of treating smoking-related illnesses.

Tobacco control also received significant support. Among the measures evaluated, 68% of respondents support banning flavor and aroma additives in cigarettes, which are used to attract beginners, and 79% support a total ban on electronic cigarettes, whose sale and advertising have already been prohibited by Anvisa since 2012.